Recovery of Shares From IEPF (Sun Pharmaceutical Industries Ltd.)

Recovery of Shares From IEPF (Sun Pharmaceutical Industries Ltd.). The recovery of shares of Sun Pharmaceutical Industries Ltd. is an important part of investor protection under Indian company law. Many shareholders fail to claim dividends for long periods or do not update their address, bank or demat details. As a result such dividends and related shares become unclaimed. Under the Companies Act, 2013, these unclaimed shares and amounts are transferred to the Investor Education and Protection Fund (IEPF) to ensure transparency and safeguard investor interests.
Sun Pharmaceutical Industries Ltd., as a leading listed pharmaceutical company follows these legal requirements and maintains accurate shareholder records. Even after the transfer to the IEPF the original shareholders or their legal heirs do not lose ownership rights. They can recover their shares by following the prescribed legal procedure, including document submission and verification with the company and its Registrar and Transfer Agent (RTA).
Company Background and History
Sun Pharmaceutical Industries Limited was founded in 1983 by Dilip Shanghvi with a vision to provide high-quality and affordable medicines. The company started its operations with a small portfolio of psychiatric medicines and gradually expanded into multiple therapeutic segments. In its early years Sun Pharma focused on chronic therapies and built a strong presence in the Indian pharmaceutical market.
Over time, the company diversified into specialty medicines, generics and active pharmaceutical ingredients (APIs) supported by strong research and development capabilities. Sun Pharma also expanded globally through strategic acquisitions and partnerships entering major markets such as the United States, Europe and emerging economies.
A significant milestone in Sun Pharma’s growth was its listing on Indian stock exchanges which enhanced transparency and investor participation. Today, Sun Pharmaceutical Industries Limited operates in more than 100 countries and is India’s largest pharmaceutical company. It is widely recognised for its innovation-driven approach, regulatory compliance and commitment to improving patient healthcare outcomes worldwide.
Financial Performance of Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. has demonstrated strong and resilient financial performance over the years, supported by its leadership in specialty pharmaceuticals, consistent R&D investments, and global expansion strategy. The company’s focus on innovation, compliance and operational excellence has strengthened its long-term growth prospects.
It performed well in 2024–25, showing steady growth across its global operations in more than 100 countries. The company expanded its specialty and innovative medicines portfolio, received important regulatory approvals and increased profits. It continued to invest in research and development while strengthening its presence in India, US and emerging markets with a strong focus on sustainability, compliance and patient-centered healthcare.

DIVIDENDS

Ex-Date

Type

Dividend (Rs)

07July, 2025

Final

5.50

06 Feb,2025

Interim

10.50

12 Jul,2024

Final

5.00

09 Feb,2024

Interim

8.50

BONUS

Announcement Date

Ex Bonus

Ratio

28 May, 2013

29 Jul, 2013

1:1

21 Apr, 2004

27 May, 2004

1:1

09 Feb, 2000

06 Mar, 2000

2:1

SPLITS

EX-Split

Old FV

New FV

25 Nov, 2010

13 Jan, 2003

Process to Recover Shares or Dividends from IEPF (Sun Pharmaceutical Industries Ltd.) 
Step 1: Check Unclaimed Dividend or Share Status
The first step is to verify whether any dividend amount or shares of Sun Pharmaceutical Industries Ltd. have been transferred to the IEPF.
Option 1: Sun Pharma – Investor Relations Website Visit the Investor Relations section of Sun Pharmaceutical Industries Ltd.’s official website and check the “Unclaimed Dividend” or “IEPF” section for shareholder details.
Option 2: IEPF Authority Website Visit the official IEPF portal and enter your Folio Number (for physical shares) or DP ID–Client ID (for demat shares) to confirm whether shares or dividends have been transferred to the IEPF.
This step confirms the exact number of shares and dividend amount eligible for recovery.
Step 2: Contact Sun Pharma’s Registrar and Share Transfer Agent (RTA)
Sun Pharmaceutical Industries Ltd. has appointed a Registrar and Share Transfer Agent (RTA) to manage shareholder-related services.
MUFG Intime India Pvt. Ltd,
C 101, 247 Park, L.B.S. Marg,
Vikhroli (West),Mumbai,
Maharashtra,400083
Tel No: 022 - 49186270
Fax: +91 22 49186060
Email: rnt.helpdesk@in.mpms.mufg.com
Website: www.in.mpms.mufg.com
 You must contact the RTA to obtain an Entitlement Letter, which confirms:

Number of shares transferred to the IEPF

Unclaimed dividend amount

Shareholder’s identity

List of documents required for filing the IEPF claim

Documents generally required:

PAN Card and Aadhaar Card

Shareholding details (Folio Number or DP ID–Client ID)

Client Master list(CML)

Contact details (mobile number and email ID)

Old dividend warrants, if available

Death Certificate of Deceased Shareholder

Once verified, the RTA issues the Entitlement Letter, which is mandatory for the IEPF claim.
Step 3: File IEPF Form-5 on the MCA Website
After receiving the Entitlement Letter, the claimant must file IEPF Form-5 online through the Ministry of Corporate Affairs (MCA) portal.
Details to be filled in Form IEPF-5:

Name, address, PAN and Aadhaar

Details of Sun Pharmaceutical Industries Ltd.

Number of shares claimed

Year-wise dividend details

Bank account details

Demat account details (DP ID and Client ID)

After submission:

Download the filled Form IEPF-5

Download the SRN acknowledgment

Both documents must be printed, signed and included in the physical submission.
Step 4: Prepare the Physical Document Set
The claimant must prepare and submit a complete set of documents to Sun Pharma’s Nodal Officer (IEPF).
Mandatory Documents:

Signed IEPF Form-5

IEPF SRN Acknowledgment

Indemnity Bond (on non-judicial stamp paper as per IEPF Rules)

Advance Stamped Receipt (duly signed by the claimant and witnesses)

Entitlement Letter issued by the RTA

Self-attested copies of PAN and Aadhaar

Cancelled cheque

Client Master List (CML) issued by the Depository Participant

Original share certificates (if shares were held in physical form)

Foreigners / NRI Documents - Self-attested copy of Passport and OCI / PIO card (if applicable)

If the Applicant Is a Legal Heir / Successor
In case the original shareholder has passed away, the legal heir or successor must submit additional documents:

Death certificate of the original shareholder

Legal heir certificate / succession certificate / probate / registered will

No Objection Certificates (NOCs) from other legal heirs, if applicable

Identity and address proof of all legal heirs

Such cases usually involve enhanced scrutiny and may require additional time for processing.
Step 5: Submission to Sun Pharma’s Nodal Officer (IEPF)
The complete document set must be sent via Speed Post or Courier to the Nodal Officer (IEPF) of Sun Pharmaceutical Industries Ltd. at its registered office.
Name - Mr. Anoop Deshpande
Address - Plot No. 201 B/1,
Western Express Highway, Goregaon (E),
Mumbai – 400 063, Maharashtra.
All documents should be properly signed, indexed and arranged to avoid delays or rejection.
Step 6: Verification by Sun Pharmaceutical Industries Ltd.
Upon receipt of documents, Sun Pharma:

Verifies shareholder details with company records

Confirms document completeness and authenticity

Ensures compliance with IEPF regulations

After verification, the company submits a verification report to the IEPF Authority generally within 30 days.
Step 7: Approval by the IEPF Authority
After review by the IEPF Authority:

Shares are credited to the claimant’s demat account

Dividend amounts are transferred to the claimant’s bank account

This completes the IEPF recovery process.
Conclusion
The transfer of unclaimed dividends and shares to the Investor Education and Protection Fund (IEPF) is an important legal step to protect investors and ensure compliance with the Companies Act, 2013. In the case of Sun Pharmaceutical Industries Limited, unclaimed shares usually arise when shareholders do not update their address, bank, demat details or are unaware of dividend payments.
The recovery process which includes checking the unclaimed status, obtaining an entitlement letter from the Registrar, filing Form IEPF-5 and approval by the IEPF Authority gives shareholders and their legal heirs a clear and lawful way to recover their shares and dividend amounts. Although the process requires careful documentation it helps prevent fraud and ensures that only genuine claims are approved.
Shareholders are therefore advised to regularly check their investment records, keep their KYC and demat details updated and claim dividends on time. If shares have already been transferred to the IEPf recovery procedure can help restore ownership and protect investor rights.
 Frequently Asked Questions (FAQs)
Q1. After how many years are Sun Pharma shares moved to IEPF?
Ans. Shares are transferred to the IEPF after the dividend on those shares remains unclaimed for seven consecutive years.
Q2. Can dividends and shares be claimed together from IEPF?
Ans. Yes, shareholders can claim both unclaimed dividends and the related shares through a single IEPF application.
Q3. Are joint shareholders required to sign the claim documents?
Ans. Yes, all surviving joint holders must sign the IEPF Form-5 and related documents.
Q4. What happens if the shareholder’s name has changed after marriage?
Ans. An affidavit and supporting documents must be submitted to explain and confirm the name change.
Q5. Can NRIs claim Sun Pharma shares from IEPF?
Ans. Yes, NRIs are eligible to file claims but must submit passport copies and other applicable documents.
Q6. Is physical submission of documents compulsory?
Ans. Yes, even after online filing physical documents must be sent to Sun Pharma’s Nodal Officer.
Q7. Can a shareholder appoint someone else to handle the process?
Ans. Yes, a duly authorised person can assist but the claimant must sign all required documents.
Q8. What happens if multiple legal heirs exist?
Ans. All legal heirs must submit consent or a succession certificate, depending on the case.
Q9. What if the demat account is inactive or closed?
Ans. The claimant must open or reactivate a demat account before submitting the IEPF claim.
Q10. How can shareholders avoid transfer of shares to IEPF in the future?
Ans. By updating KYC details, keeping demat accounts active and regularly tracking dividend announcements.

The recovery of shares of Sun Pharmaceutical Industries Ltd. is an important part of investor protection under Indian company law. Many shareholders fail to claim dividends for long periods or do not update their address, bank or demat details. As a result such dividends and related shares become unclaimed. Under the Companies Act, 2013, these unclaimed shares and amounts are transferred to the Investor Education and Protection Fund (IEPF) to ensure transparency and safeguard investor interests.

Sun Pharmaceutical Industries Ltd., as a leading listed pharmaceutical company follows these legal requirements and maintains accurate shareholder records. Even after the transfer to the IEPF the original shareholders or their legal heirs do not lose ownership rights. They can recover their shares by following the prescribed legal procedure, including document submission and verification with the company and its Registrar and Transfer Agent (RTA).

Company Background and History

Sun Pharmaceutical Industries Limited was founded in 1983 by Dilip Shanghvi with a vision to provide high-quality and affordable medicines. The company started its operations with a small portfolio of psychiatric medicines and gradually expanded into multiple therapeutic segments. In its early years Sun Pharma focused on chronic therapies and built a strong presence in the Indian pharmaceutical market.

Over time, the company diversified into specialty medicines, generics and active pharmaceutical ingredients (APIs) supported by strong research and development capabilities. Sun Pharma also expanded globally through strategic acquisitions and partnerships entering major markets such as the United States, Europe and emerging economies.

A significant milestone in Sun Pharma’s growth was its listing on Indian stock exchanges which enhanced transparency and investor participation. Today, Sun Pharmaceutical Industries Limited operates in more than 100 countries and is India’s largest pharmaceutical company. It is widely recognised for its innovation-driven approach, regulatory compliance and commitment to improving patient healthcare outcomes worldwide.

Financial Performance of Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd. has demonstrated strong and resilient financial performance over the years, supported by its leadership in specialty pharmaceuticals, consistent R&D investments, and global expansion strategy. The company’s focus on innovation, compliance and operational excellence has strengthened its long-term growth prospects.

It performed well in 2024–25, showing steady growth across its global operations in more than 100 countries. The company expanded its specialty and innovative medicines portfolio, received important regulatory approvals and increased profits. It continued to invest in research and development while strengthening its presence in India, US and emerging markets with a strong focus on sustainability, compliance and patient-centered healthcare.

	DIVIDENDS
Ex-Date	Type	Dividend (Rs)
07July, 2025	Final	5.50
06 Feb,2025	Interim	10.50
12 Jul,2024	Final	5.00
09 Feb,2024	Interim	8.50
	BONUS
Announcement Date	Ex Bonus	Ratio
28 May, 2013	29 Jul, 2013	1:1
21 Apr, 2004	27 May, 2004	1:1
09 Feb, 2000	06 Mar, 2000	2:1
	SPLITS
EX-Split	Old FV	New FV
25 Nov, 2010	5	1
13 Jan, 2003	10	5

Process to Recover Shares or Dividends from IEPF (Sun Pharmaceutical Industries Ltd.)

Step 1: Check Unclaimed Dividend or Share Status

The first step is to verify whether any dividend amount or shares of Sun Pharmaceutical Industries Ltd. have been transferred to the IEPF.

Option 1: Sun Pharma – Investor Relations Website
Visit the Investor Relations section of Sun Pharmaceutical Industries Ltd.’s official website and check the “Unclaimed Dividend” or “IEPF” section for shareholder details.

Option 2: IEPF Authority Website
Visit the official IEPF portal and enter your Folio Number (for physical shares) or DP ID–Client ID (for demat shares) to confirm whether shares or dividends have been transferred to the IEPF.

This step confirms the exact number of shares and dividend amount eligible for recovery.

Step 2: Contact Sun Pharma’s Registrar and Share Transfer Agent (RTA)

Sun Pharmaceutical Industries Ltd. has appointed a Registrar and Share Transfer Agent (RTA) to manage shareholder-related services.

MUFG Intime India Pvt. Ltd,

C 101, 247 Park, L.B.S. Marg,

Vikhroli (West),Mumbai,

Maharashtra,400083

Tel No: 022 - 49186270

Fax: +91 22 49186060

Email: rnt.helpdesk@in.mpms.mufg.com

Website: www.in.mpms.mufg.com

You must contact the RTA to obtain an Entitlement Letter, which confirms:

Number of shares transferred to the IEPF
Unclaimed dividend amount
Shareholder’s identity
List of documents required for filing the IEPF claim

Documents generally required:

PAN Card and Aadhaar Card
Shareholding details (Folio Number or DP ID–Client ID)
Client Master list(CML)
Contact details (mobile number and email ID)
Old dividend warrants, if available
Death Certificate of Deceased Shareholder

Once verified, the RTA issues the Entitlement Letter, which is mandatory for the IEPF claim.

Step 3: File IEPF Form-5 on the MCA Website

After receiving the Entitlement Letter, the claimant must file IEPF Form-5 online through the Ministry of Corporate Affairs (MCA) portal.

Details to be filled in Form IEPF-5:

Name, address, PAN and Aadhaar
Details of Sun Pharmaceutical Industries Ltd.
Number of shares claimed
Year-wise dividend details
Bank account details
Demat account details (DP ID and Client ID)

After submission:

Download the filled Form IEPF-5
Download the SRN acknowledgment

Both documents must be printed, signed and included in the physical submission.

Step 4: Prepare the Physical Document Set

The claimant must prepare and submit a complete set of documents to Sun Pharma’s Nodal Officer (IEPF).

Mandatory Documents:

Signed IEPF Form-5
IEPF SRN Acknowledgment
Indemnity Bond (on non-judicial stamp paper as per IEPF Rules)
Advance Stamped Receipt (duly signed by the claimant and witnesses)
Entitlement Letter issued by the RTA
Self-attested copies of PAN and Aadhaar
Cancelled cheque
Client Master List (CML) issued by the Depository Participant
Original share certificates (if shares were held in physical form)
Foreigners / NRI Documents - Self-attested copy of Passport and OCI / PIO card (if applicable)

If the Applicant Is a Legal Heir / Successor

In case the original shareholder has passed away, the legal heir or successor must submit additional documents:

Death certificate of the original shareholder
Legal heir certificate / succession certificate / probate / registered will
No Objection Certificates (NOCs) from other legal heirs, if applicable
Identity and address proof of all legal heirs

Such cases usually involve enhanced scrutiny and may require additional time for processing.

Step 5: Submission to Sun Pharma’s Nodal Officer (IEPF)

The complete document set must be sent via Speed Post or Courier to the Nodal Officer (IEPF) of Sun Pharmaceutical Industries Ltd. at its registered office.

Name - Mr. Anoop Deshpande

Address - Plot No. 201 B/1,

Western Express Highway, Goregaon (E),

Mumbai – 400 063, Maharashtra.

All documents should be properly signed, indexed and arranged to avoid delays or rejection.

Step 6: Verification by Sun Pharmaceutical Industries Ltd.

Upon receipt of documents, Sun Pharma:

Verifies shareholder details with company records
Confirms document completeness and authenticity
Ensures compliance with IEPF regulations

After verification, the company submits a verification report to the IEPF Authority generally within 30 days.

Step 7: Approval by the IEPF Authority

After review by the IEPF Authority:

Shares are credited to the claimant’s demat account
Dividend amounts are transferred to the claimant’s bank account

This completes the IEPF recovery process.

Conclusion

The transfer of unclaimed dividends and shares to the Investor Education and Protection Fund (IEPF) is an important legal step to protect investors and ensure compliance with the Companies Act, 2013. In the case of Sun Pharmaceutical Industries Limited, unclaimed shares usually arise when shareholders do not update their address, bank, demat details or are unaware of dividend payments.

The recovery process which includes checking the unclaimed status, obtaining an entitlement letter from the Registrar, filing Form IEPF-5 and approval by the IEPF Authority gives shareholders and their legal heirs a clear and lawful way to recover their shares and dividend amounts. Although the process requires careful documentation it helps prevent fraud and ensures that only genuine claims are approved.

Shareholders are therefore advised to regularly check their investment records, keep their KYC and demat details updated and claim dividends on time. If shares have already been transferred to the IEPf recovery procedure can help restore ownership and protect investor rights.

Frequently Asked Questions (FAQs)

Q1. After how many years are Sun Pharma shares moved to IEPF?

Ans. Shares are transferred to the IEPF after the dividend on those shares remains unclaimed for seven consecutive years.

Q2. Can dividends and shares be claimed together from IEPF?

Ans. Yes, shareholders can claim both unclaimed dividends and the related shares through a single IEPF application.

Q3. Are joint shareholders required to sign the claim documents?

Ans. Yes, all surviving joint holders must sign the IEPF Form-5 and related documents.

Q4. What happens if the shareholder’s name has changed after marriage?

Ans. An affidavit and supporting documents must be submitted to explain and confirm the name change.

Q5. Can NRIs claim Sun Pharma shares from IEPF?

Ans. Yes, NRIs are eligible to file claims but must submit passport copies and other applicable documents.

Q6. Is physical submission of documents compulsory?